Cargando…

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by extracellular amyloid β (Aβ) and intraneuronal tau protein aggregations. One risk factor for developing AD is the APOE gene coding for the apolipoprotein E protein (apoE). Humans have three versions of APOE gene: ε...

Descripción completa

Detalles Bibliográficos
Autores principales:	Husain, Mohammed Amir, Laurent, Benoit, Plourde, Mélanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925634/ https://www.ncbi.nlm.nih.gov/pubmed/33679311 http://dx.doi.org/10.3389/fnins.2021.630502

Ejemplares similares

Lipids in the Physiopathology of Hereditary Spastic Paraplegias
por: Darios, Frédéric, et al.
Publicado: (2020)

Lipid Transport and Metabolism at the Blood-Brain Interface: Implications in Health and Disease
por: Pifferi, Fabien, et al.
Publicado: (2021)

Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease
por: García-Morales, Victoria, et al.
Publicado: (2021)

ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
por: Lanfranco, Maria Fe, et al.
Publicado: (2020)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs
por: Zolezzi, Juan M., et al.
Publicado: (2014)

Physiopathological Role of the Vesicular Nucleotide Transporter (VNUT) in the Central Nervous System: Relevance of the Vesicular Nucleotide Release as a Potential Therapeutic Target
por: Miras-Portugal, María T., et al.
Publicado: (2019)

Brain pericyte biology: from physiopathological mechanisms to potential therapeutic applications in ischemic stroke
por: Fu, Jiaqi, et al.
Publicado: (2023)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease
por: Yassine, Hussein N., et al.
Publicado: (2020)

Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors
por: Ledonne, Ada, et al.
Publicado: (2017)

Commentary: Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
por: Dzianok, Patrycja, et al.
Publicado: (2020)

Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?
por: Charron, Giselle, et al.
Publicado: (2014)

APOEε4 and risk of Alzheimer’s disease – time to move forward
por: Lefterov, Iliya, et al.
Publicado: (2023)

The Role of Insulin-Like Growth Factor-I in the Physiopathology of Hearing
por: Murillo-Cuesta, Silvia, et al.
Publicado: (2011)

Physiopathological Relevance of D-Serine in the Mammalian Cochlea
por: Wang, Jing, et al.
Publicado: (2021)

Cell death: physiopathological and therapeutic implications
por: Lulli, M, et al.
Publicado: (2010)

Similar Genetic Architecture of Alzheimer’s Disease and Differential APOE Effect Between Sexes
por: Wang, Hao, et al.
Publicado: (2021)

Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
por: Mishra, Aarti, et al.
Publicado: (2018)

Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation
por: Valencia-Olvera, Ana C., et al.
Publicado: (2023)

The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer’s Disease: Exploring Interactions With Sex
por: Liu, Ying, et al.
Publicado: (2021)

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
por: Hou, Min, et al.
Publicado: (2021)

Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
por: Dai, Jingting, et al.
Publicado: (2018)

The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease
por: Fernandez, Celia G., et al.
Publicado: (2019)

Oscillatory hyperactivity and hyperconnectivity in young APOE-ɛ4 carriers and hypoconnectivity in Alzheimer’s disease
por: Koelewijn, Loes, et al.
Publicado: (2019)

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
por: Raulin, Ana-Caroline, et al.
Publicado: (2022)

Postperfusion lung syndrome: physiopathology and therapeutic options
por: Yuan, Shi-Min
Publicado: (2014)

Midlife Lifestyle Activities Moderate APOE ε4 Effect on in vivo Alzheimer’s Disease Pathologies
por: Jeon, So Yeon, et al.
Publicado: (2020)

α-synuclein and p53 functional interplay in physiopathological contexts
por: Alves da Costa, Cristine, et al.
Publicado: (2016)

Multimodal Neuroimaging in Alzheimer’s Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle
por: Chételat, Gaël
Publicado: (2018)

Understanding the Physiopathology Behind Axial and Radial Diffusivity Changes—What Do We Know?
por: Winklewski, Pawel J., et al.
Publicado: (2018)

Physiopathology of shock
por: Bonanno, Fabrizio Giuseppe
Publicado: (2011)

The Physiopathology of Cancer
por: Velardo, Joseph Thomas
Publicado: (1959)

Synapses, Microglia, and Lipids in Alzheimer’s Disease
por: Paasila, Patrick J., et al.
Publicado: (2022)

APOE and Alzheimer’s Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches.
por: Serrano-Pozo, Alberto, et al.
Publicado: (2021)

ApoE4: an emerging therapeutic target for Alzheimer’s disease
por: Safieh, Mirna, et al.
Publicado: (2019)

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
por: Li, Zonghua, et al.
Publicado: (2020)

Interplay Between Microglia and Alzheimer’s Disease—Focus on the Most Relevant Risks: APOE Genotype, Sex and Age
por: Chen, Yanting, et al.
Publicado: (2021)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer’s Disease
por: Jiang, Shan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fdl293uulqkr43kf0hh19d5oa7